Table 5.
Recommendation |
Funding agencies |
Priority decision-makers |
Producers |
Users |
Evaluators |
||||
---|---|---|---|---|---|---|---|---|---|
International | National | International organizations | National research councils | Institutions (universities, research institutes, NGOs), networks | Researchers (established and learning) | International organizations | National and sub-national health services | ||
Adequate allocation of resources to quality evaluation research alongside investments in the quality of the science, scientists, and science communication. |
+++ |
++ |
|
++ |
|
|
|
|
|
Systematic attention to indicator framing, selection, measurement (multiple data sources and valid standards to enhance quality), and analysis. |
+ |
+ |
|
|
++ |
++ |
+ |
+ |
+++ |
Development of indicators which better encompass relationships with knowledge users. |
|
|
++ |
++ |
++ |
++ |
++ |
++ |
+++ |
Disaggregation of indicator data according to equity categories. |
+ |
+ |
|
|
++ |
++ |
++ |
++ |
+++ |
Systematic consideration of assumptions, pre-conditions, or measurement confounders associated with the evaluations. |
|
|
|
|
|
++ |
|
|
+++ |
Greater attention to evaluation design, use of clear conceptual frameworks, systematic linkage of indicators in keeping with theories of change. |
+ |
+ |
|
|
|
++ |
|
|
+++ |
Development of comprehensive, prospective systems for health RCS indicator monitoring and evaluation, in which long-term impact is considered throughout the entire project cycle. |
++ |
++ |
+ |
+ |
++ |
++ |
+ |
+ |
++ |
Separation out of three components of the upper level– provincial-national research environment, international-global research environment, and research networks. | ++ | ++ | ++ | ++ | + | + | + | +++ |
*Role designated as + small, ++ medium, or +++ large.